Synapsins are synaptic-vesicle-associated phosphoproteins implicated in the regulation of neurotransmitter release and excitability of neuronal networks. Mutation of synapsin genes in mouse and human causes epilepsy. To understand the role of the highly conserved synapsin domain E in the dynamics of release from mammalian inhibitory neurons, we generated mice that selectively overexpress the most conserved part of this domain in cerebellar Purkinje cells. At Purkinje-cell-nuclear-neuron synapses, transgenic mice were more resistant to depression induced by short or prolonged high-frequency stimulations. The increased synaptic performance was accompanied by accelerated release kinetics and shorter synaptic delay. Despite a marked decrease in the total number of synaptic vesicles, vesicles at the active zone were preserved or slightly increased. The data indicate that synapsin domain E increases synaptic efficiency by accelerating both the kinetics of exocytosis and the rate of synaptic vesicle cycling and decreasing depression at the inhibitory Purkinje-cell-nuclear-neuron synapse. These effects may increase the sensitivity of postsynaptic neurons to inhibition and thereby contribute to the inhibitory control of network activity.

Download full-text PDF

Source
http://dx.doi.org/10.1242/jcs.03194DOI Listing

Publication Analysis

Top Keywords

synapsin domain
12
synaptic vesicles
8
cerebellar purkinje
8
purkinje cells
8
synaptic
6
synapsin
4
domain accelerates
4
accelerates exoendocytotic
4
exoendocytotic cycle
4
cycle synaptic
4

Similar Publications

Article Synopsis
  • The study investigates the impact of Shank3 deficiency on dopaminergic neurons in mouse models relevant to autism.
  • Significant reductions in neurite outgrowth and altered morphology of dopaminergic neurons were observed in Shank3-deficient mice compared to wild-type (WT) mice.
  • Although there were no changes in the expression of synaptic proteins, shifts in dopaminergic receptor gene expression suggest structural alterations may contribute to autistic symptoms in these models.
View Article and Find Full Text PDF

Background: This study investigates the effects of intranasal dantrolene nanoparticles on inflammation and programmed cell death by pyroptosis in 5XFAD Alzheimer's Disease (AD) mice.

Methods: 5XFAD and wild type (WT) B6SJLF1/J mice were treated with intranasal dantrolene nanoparticles (5 mg/kg), daily, Monday to Friday, for 12 weeks continuously, starting at 9 months of age. Blood and brain were harvested at 13 months of age, one month after completion of 12 weeks intranasal dantrolene nanoparticle treatment.

View Article and Find Full Text PDF
Article Synopsis
  • * Intranasal LiCl in RFV was found to have a higher brain/blood lithium concentration ratio, providing better protection against memory loss and depressive behaviors without causing side effects or organ toxicity.
  • * The neuroprotective effects of intranasal LiCl are linked to its ability to inhibit inflammation and the pyroptosis pathway, suggesting it could be a promising treatment for dementia and depression with minimal risks.
View Article and Find Full Text PDF

Betaine improves METH-induced depressive-like behavior and cognitive impairment by alleviating neuroinflammation via NLRP3 inflammasome inhibition.

Prog Neuropsychopharmacol Biol Psychiatry

December 2024

College of Forensic Medicine, Hebei Medical University, Hebei Key Laboratory of Forensic Medicine, Collaborative Innovation Center of Forensic Medical Molecular Identification, Hebei Province, Shijiazhuang 050017, PR China; Research Unit of Digestive Tract Microecosystem Pharmacology and Toxicology, Chinese Academy of Medical Sciences, Hebei Province, Shijiazhuang 050017, PR China. Electronic address:

Article Synopsis
  • * The study tested whether betaine could protect against these negative effects in mice given METH, showing that higher doses of betaine improved depressive-like behaviors and cognitive function.
  • * Betaine not only helped restore synaptic health and reduced inflammation in the brain but also showed promise as a potential treatment for preventing and mitigating substance abuse issues.
View Article and Find Full Text PDF

Members of the synaptophysin and synaptogyrin family are vesicle proteins with four transmembrane domains. In spite of their abundance in synaptic vesicle (SV) membranes, their role remains elusive and only mild defects at the cellular and organismal level are observed in mice lacking one or more family members. Here, we show that coexpression with synapsin in fibroblasts of each of the four brain-enriched members of this family-synaptophysin, synaptoporin, synaptogyrin 1, and synaptogyrin 3-is sufficient to generate clusters of small vesicles in the same size range of SVs.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!